Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine plus low-dose naloxone or dexmedetomidine for post-cesarean analgesia
IRCT20161126031095N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Morphine + naloxone + bupivacaine, Dexmedetomidine + bupivacaine and Bupivacaine alone (3 arms). Primary endpoints: Pain intensity, Sedation scores and 1 more. Started Aug 2023; status: completed.
02
Drugs
morphinenaloxonedexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20161126031095N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161126031095N5.